Recent studies have demonstrated the therapeutic potential of mesenchymal stem cells (MSCs) for the treatment of acute inflammatory injury and bacterial pneumonia, but their therapeutic applications in mycobacterial infections have not been investigated. In this study, we demonstrated the use of MSCs as a novel therapeutic strategy against Mycobacterium abscessus (M. abscessus), which is the most drug-resistant and difficult-to-treat mycobacterial pathogen. The systemic intravenous injection of MSCs not only improved mouse survival but also enhanced bacterial clearance in the lungs and spleen. Additionally, MSCs enhanced IFN-c, TNFa, IL-6, MCP-1, nitric oxide (NO) and PGE 2 production and facilitated CD4 1 /CD8 1 T cell, CD11b high macrophage, and monocyte recruitment in the lungs of M. abscessus-infected mice. To precisely elucidate the functions of MSCs in M. abscessus infection, an in vitro macrophage infection system was used. MSCs caused markedly increased NO production via NF-jB activation in M. abscessus-infected macrophages cultured in the presence of IFN-c. Inhibiting NO or NF-jB signaling using specific inhibitors reduced the antimycobacterial activity of MSCs. Furthermore, the cellular crosstalk between TNF-a released from IFN-c-stimulated M. abscessus-infected macrophages and PGE 2 produced by MSCs was necessary for the mycobacterial-killing activity of the macrophages. Finally, the importance of increased NO production in response to MSC administration was confirmed in the mouse M. abscessus infection model. Our results suggest that MSCs may offer a novel therapeutic strategy for treating this drug-resistant mycobacterial infection by enhancing the bacterial-killing power of macrophages. STEM CELLS 2016; 00:000-000
INTRODUCTION
Mesenchymal stem cells (MSCs) are multipotent stromal cells with the capacity to differentiate into multiple cell types such as osteoblasts, adipocytes, and chondroblasts [1] . Previous studies have investigated the therapeutic potential of MSCs for the treatment of various conditions, including bone/ cartilage diseases, graft-versus-host disease, autoimmune diseases, liver diseases, and can-cer [1] [2] [3] . These works mostly focused on the immune-regulatory properties and tissuereparative functions of MSCs. MSCs express immunosuppressive molecules and various growth factors that facilitate tissue repair and maintain immune homeostasis [1, 4] . The immunosuppressive properties of MSCs are well characterized, but the immuneenhancing ability of MSCs is not well defined. In certain immune environments, particularly when low-level inflammation exists, MSCs enhance, rather than suppress, the immune response [1, [5] [6] [7] .
Although the immunomodulatory properties of MSCs have been extensively investigated, the association of MSCs with infectious diseases still remains unknown. Previous studies have provided evidence of the beneficial effects of MSCs in sepsis models following lipopolysaccharide (LPS) injection or cecal ligation and puncture [8] [9] [10] . In addition, other studies have demonstrated that MSCs have the ability to clear extracellular E. coli by increasing the antimicrobial peptide LL-37, by upregulating lipocalin 2 production or by enhancing the phagocytic activity of host immune cells [11, 12] .
On the other hand, Mycobacterium tuberculosis (Mtb) uses MSCs to evade the host immune system because they provide a niche for maintaining dormancy [13, 14] . Mycobacterium leprae (ML) reprogram adult Schwann cells to become stem-like cells and use the plasticity of the resulting cellular niche to promote the dissemination of the infection [15] . In addition, Chlamydia trachomatis evades host immunity by inhibiting NO production in human MSCs (hMSCs) [16] .
However, whether MSCs have a beneficial effect in infections with Mycobacterium species (spp.) remains unknown. Mycobacterium abscessus (M. abscessus sensu stricto) is an intracellular pathogen that belongs to the rapidly growing family of Mycobacterium spp. M. abscessus is an emerging respiratory pathogen that causes pulmonary infections in patients with cystic fibrosis and chronic lung diseases such as bronchiectasis [17] [18] [19] [20] . Furthermore, M. abscessus is resistant to many antibiotics, thus making it difficult to obtain a favorable treatment outcome. Unfortunately, there are no reliable treatment regimens for M. abscessus infection, and better treatment options are urgently needed [17] [18] [19] [20] .
Recent studies have shown that M. abscessus can maintain an infectious status in certain immune-deficient murine models, indicating that M. abscessus infection can be immunologically controllable if a key immune responder exists [21, 22] . Thus, an alternative treatment approach to antibiotic therapy is needed for relatively low virulent but highly drugresistant Mycobacterium spp. such as M. abscessus. Because MSCs have a strong potential to alter the host immune response to an immunological condition, we investigated the therapeutic potential of MSCs in a murine model and in the macrophage system of M. abscessus infection. We hypothesized that MSCs may control M. abscessus growth via enhancing the mycobacterial killing activity of MSCs. We also investigated whether the crosstalk between MSCs and macrophages can kill M. abscessus, and we identified the critical factors of MSCs that enhance the intracellular killing activity of macrophages at the molecular level. Finally, we confirmed the therapeutic and mechanistic effects of MSC in a murine M. abscessus-infection model.
MATERIAL AND METHODS

Ethics Statement
All animal experiments were performed in accordance with the Korea Food and Drug Administration (KFDA) guidelines. The experimental protocols used in this study were reviewed and approved by the Ethics Committee and Institutional Animal Care and Use Committee (Permit Number: 2013-0421-3) of the Laboratory Animal Research Center at Yonsei University College of Medicine (Seoul, Korea).
Reagents and Antibodies
Anti-iNOS Ab, antiphosphorylated p38 Ab, antiphosphorylated STAT-1 Ab and anti-IRF-1 Ab were purchased from Cell Signaling Technology, Inc. (Danvers, MA, www.cellsignal.com). Anti-GAPDH Ab, anti-Lamin B Ab and anti-Cox-2 Ab were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, www.scbt. com). HRP-conjugated anti-mouse IgG Ab and HRP-conjugated anti-rabbit Ab were obtained from Calbiochem (San Diego, CA, www.merckmillipore.com), and anti-b-actin Ab was purchased from Sigma (St. Louis, MO, www.sigmaaldrich.com). TNF-a, IL-12p70, IL-10, IL-6, IL-4, IL-17, MCP-1, and IFN-c levels were analyzed using ELISA kits purchased from eBioscience (San Diego, CA, www.ebioscience.com). PGE 2 levels were analyzed using ELISA kits purchased from R&D System (Minneapolis, MN, www.rndsystems.com). FITC-conjugated anti-CD11b Ab, PE-cy7conjugated anti-CD11c Ab, Alexa Fluor 700-conjugated anti-Gr-1 Ab, Pacific blue-conjugated anti-CD3 Ab, PerCP 5.5-conjugated anti-CD4 Ab, APC-eFluor780-conjugated anti-CD8 Ab, APCconjugated anti-F4/80 Ab and TNF-a-neutralizing Ab were purchased from eBioscience. NG-monomethyl-L-arginine monoacetate salt (L-NMMA), PGE 2 , SB203580, Bay-11-7082, and celecoxib were purchased from Sigma.
Mouse MSC Isolation, In Vitro Expansion
C57BL/6 and iNOS 2/2 (NOS2 tm1Lau ) purchased from Jackson laboratory (Bar Harbor, ME, www.jax.org). COX-2 2/2 mice were kindly provided by professor Young Myeong Kim (Kangwon National University, South Korea). Bone marrow cells were collected from 6-week-old mice that were killed by CO 2 -inhalation. Their femurs and tibiae were carefully cleaned of adherent soft tissue and harvested by flushing with Dulbecco's modified Eagle's medium (DMEM) (HyClone, Logan, UT 84321, low glucose, www. gelifesciences.com) supplemented with 10% heat-inactivated fetal bovine serum (FBS; HyClone) and penicillin/streptomycin (100 U/ml and 100 lg/ml; HyClone). After washing and centrifugation at 400g for 5 minutes, mononucleated cells were isolated from marrow cells followed by density-gradient centrifugation (1.077 g/cm 3 ) using HISTOPAQUE-1077 (Sigma). After then, cells were immunodepleted of granulomonocytic cells using CD11b 1 micromagnetic beads (Miltenyi Biotec, Bergisch-Gladbach, Germany, www.miltenyibiotec.com). The residual cells were cultured in DMEM (Hyclone) containing 10% FBS and penicillin/streptomycin (100 U/ml and 100 lg/ml) supplemented at 378C in a 5% CO 2 humidified incubator. The nonadherent cells were removed after 72-96 hours, adherent cells were harvested by trypsinization (0.05% trypsin-EDTA, Gibco-Invitrogen, Carlsbad, CA, www.thermofisher.com) when reaching 90% confluence, and then replated. The medium was changed every 3-4 days.
Murine Bone Marrow-Derived Macrophage Generation
Murine bone marrow-derived macrophages (BMDMs) were obtained as previously described [23] . Briefly, female C57BL/6J mice were euthanized by CO 2 asphyxiation. Bone marrow cells were cultured for 6 days in DMEM (HyClone, Logan, UT) containing 100 U/ml penicillin, 100 lg/ml streptomycin, 10% FBS (Invitrogen, Carlsbad, CA, www.thermofisher.com), and 20 ng/ ml recombinant mouse macrophage colony stimulating factor (M-CSF; R&D Systems) at 378C in the presence of 5% CO 2 . 2 MSCs Enhance the Antimycobacterial Activity V C AlphaMed Press 2016
In Vitro Coculture Studies of MSCs and BMDMs
To directly prepare mixed coculture systems, MSCs and BMDMs were suspended in RPMI1640 supplemented with 10% FBS, 100 U/ml penicillin and 100 lg/ml streptomycin. BMDMs were plated in 24-well plates at a density of 3 3 10 5 cells/wells. After 24 hours, MSCs (3 3 10 4 cells) were added to the plates (BMDM:MSC ratio of 10:1). To prepare coculture systems using transwell plates, MSCs (3 3 10 4 cells) were added into transwells (0.4 lm pore size) in 24-well plates of cultured BMDMs (BMDM:MSC ratio of 10:1). To produce MSC-conditioned medium (CM), MSCs (3 3 10 4 cells) were plated in 24-well plates for 24 hours. The supernatants were collected, centrifuged and stored at 2308C.
Bacterial Culture
M. abscessus culture was performed as previously described [22, 24] . The M. abscessus ATCC19977 T strain was obtained from the American Type Culture Collection (ATCC; Manassas, VA). M. abscessus ATCC19977 T originally showed a smooth morphotype, and an isogenic rough variant (M. abs-R) was isolated from the lungs of a C57BL/6J mouse infected with the smooth morphotypic strain of M. abscessus ATCC19977 T during macrolide treatment. The rough isogenic strains of M. abscessus ATCC19977 T were confirmed to have an identical genotype by variable number tandem repeat analysis [24] . For red fluorescent protein (RFP) expression, M. abs-R was transformed with pMV261-ERFP.
Animals and Infection
In an initial animal infection study conducted to analyze the in vivo effect of MSCs on bacterial colony-forming units (CFUs) in the lungs and spleens of M. abs-R-infected mice, C57BL/6J mice were infected with aerosolized M. abs-R (4.0 3 10 5 CFUs/mouse). At specific time points post-infection, the mice were euthanized, and the lungs and spleens were aseptically collected for bacterial counts. In some experiments, to analyze the in vivo effect of MSCs on the survival rate, mice were infected via the intravenous injection of M. abs-R (1.6 3 10 7 CFUs/mouse) through the tail vein. The numbers of viable bacteria in the organs were assessed by plating serial dilutions of the organ homogenates onto 7H10-OADC agar plates. Colonies were counted after 3-5 days of incubation at 378C. To inhibit NO production in mice, C57BL/6J mice were given a 0.25% solution of aminoguanidine hydrochloride (AG; Sigma) in sterilized drinking water ad libitum beginning 1 day prior to M. abs-R infection.
Collection of Bronchoalveolar Lavage (BAL) Fluids and BAL Cells
BAL fluid samples were harvested by infusing 1 ml of ice-cold PBS through a 25-gauge blunt needle into the lungs via the trachea [22] . This procedure was followed by gently aspirating the fluid into a syringe at 5 and 10 days post-infection. BAL fluids and BAL cells were separated using centrifugation at 13,000g for 10 minutes at 48C.
Flow Cytometric Analysis
Cell surface staining was performed with specifically labeled fluorescent-conjugated Abs, as recently described [25] . The fluorescence was measured by flow cytometry (FACSVerse, BD Biosciences, www.bdbiosciences.com), and the data were analyzed using FlowJo data analysis software (TreeStar, Inc., www. flowjo.com).
Enzyme-Linked Immunosorbent Assay (ELISA)
Cell culture supernatants or bronchoalveolar lavage fluid (BALF) samples from mice were collected, sterile-filtered, and stored at 2808C until use. Cytokine levels were measured using ELISAs with commercial reagent kits, following the manufacturers' instructions.
Bacterial Survival in BMDMs
BMDMs were infected with M. abscessus for 4 hours at a ratio of one CFU per macrophage. The infected BMDMs were washed with DMEM to remove extracellular bacteria and cultivated at 378C in 5% CO 2 . After incubation, the cells were lysed with 0.05% Triton-X 100, and the lysates were plated in 10-fold serial dilutions onto 7H10 agar (Becton Dickinson, Franklin Lakes, NJ, www.bdbiosciences.com) to quantify the number of viable bacteria. Colonies were counted after 3-5 days of incubation at 378C.
Immunoblotting Analysis and Subcellular Fractionation
Immunoblotting analysis and subcellular fractionation were performed as previously described [26] .
Reverse Transcription-PCR Analysis
Reverse transcription (RT)-PCR was performed as previously described [27] . The following primer sequences were used: iNOS, 5 0 -gtttctggcagcagcggctc-3 0 (sense) and 5 0 -gctcctcgctcaag ttcagc-3 0 (antisense); b-actin, 5 0 -cgtgggccgccctaggcaccaggg-3 0 (sense) and 5 0 -gggaggaagaggatgcggcagtgg-3 0 (antisense); Cox-2, 5 0 -tctccaacctctcctactac-3 0 (sense) and 5 0 -gcacgtagtcttcgatcact-3 0 (antisense); IL-6, 5 0 -atgaactccttctccacaagcgc-3 0 (sense) and 5 0gaagagccctcaggctggactg-3 0 (antisense); and IL-10, 5 0 -ccagttttacc tggtagaagtgatg-3 0 (sense) and 5 0 -tgtctaggtcctggagtccagcagctc-3 0 (antisense).
Immunocytochemistry
The cells were then fixed in 4% paraformaldehyde and permeabilized in 0.1% Triton X-100. The samples were then blocked with CAS-Block (Invitrogen) before being incubated with anti-iNOS Ab, anti-F4/80 Ab for 2 hours at room temperature (RT). The samples were washed with phosphate-buffered saline with 0.1% Tween-20 (PBS/T), incubated with Alexa Fluor 488conjugated secondary antibody for 1 hour and then stained with 1 lg/ml DAPI for 10 minutes at RT. Samples were observed using a confocal laser scanning microscope (FV1000; Olympus, Japan, www.olympus-lifescience.com).
Immunohistochemistry
At the end of the experiments, tissues were fixed overnight in formalin and embedded in paraffin. The sections were deparaffinized in xylene and washed in PBS. After washing, the sections were subjected to antigen retrieval in boiling citric acid buffer (10 mM, pH 6), and nonspecific proteins were then blocked with CAS-Block. The slides were then incubated with anti-iNOS Ab and anti-F4/80 Ab at 48C overnight. The slides were washed with PBS/T and then incubated with anti-rabbit IgG Alexa Fluor 488-conjugated secondary antibody (Invitrogen) for 1 hour at RT. The cells were also stained with DAPI Kim, Cha, Kim et al.
(Sigma) and Texas Red-phalloidin (Invitrogen) to visualize cell shape and were then observed using an FV1000.
Nitric Oxide Measurement
NO production was monitored in the extracellular medium of macrophages by assessing the nitrite levels using commercial Griess reagent kits, following the manufacturer's instructions. The samples were measured at 540 nm on a microplate reader (Epoch, BioTek, Winooski, VT, www.biotek.com).
Statistical Analysis
All experiments were repeated at least three times with consistent results. Significant differences between samples were assessed with Tukey's multiple comparison tests using Graph-Pad Prism software (San Diego, CA). The data in the graphs are expressed as the mean 6 SEM. *, p < .05; **, p < .01 and ***, p < .001 were considered statistically significant. Survival curves were analyzed using the Kaplan-Meyer log-rank test.
RESULTS
Generation and Characterization of MSCs
The cell morphotypes were observed to confirm that the isolated bone marrow-derived MSCs had a typical phenotype. The cells were highly proliferative in in vitro culture and exhibited archetypal fibroblastic morphology (Supporting Information Fig.   S1A ). Flow cytometric analysis demonstrated that more than 90% of the cells were Sca-1-, CD29-, CD44-and CD90-positive, while less than 1% were CD117-and CD45-positive (Supporting Information Fig. S1B ). To confirm their multipotent ability, MSCs were exposed to differentiation medium. Cell type-specific staining showed that the MSCs differentiated into adipocytes and chondrocytes (Supporting Information Fig. S1C ).
MSCs Enhance M. abscessus Clearance and Improve Mouse Survival
Based on colony morphology on solid growth media, there are two variants of M. abscessus, designated as the smooth (S) and rough (R) morphotypes [28] . The R variant of M. abscessus is considered more pathogenic in humans [22, 29, 30] . Therefore, we used a hypervirulent rough variant of M. abscessus (M. abs-R) in this study. To test the effect of MSCs on mycobacterial growth, we aerogenically infected C57BL/6J mice with M. abs-R (4.0 3 10 5 CFUs/mouse), and MSCs (2.5 3 10 5 cells/mouse) were intravenously administered one day post-infection ( Fig. 1A ). As shown in Fig. 1B , MSCs strongly inhibited bacterial CFUs in the lungs at 10 days postinfection. Furthermore, MSCs also significantly repressed M. abs-R dissemination from the primary infection site of the lungs to the spleen (Fig. 1C ).
Previous studies have thoroughly documented the inability of M. abscessus aerosol or intratracheal infection models to induce lethality in mice [21, 31, 32] . According to our previous study, M. abs-R could induce mice lethality by the intravenous route [22] . Therefore, to investigate the effect of MSCs on the survival of M. abs-R-infected mice, we intravenously infected C57BL/6J mice with abs-R (1.6 3 10 7 CFUs/ mouse). At one day post-infection, MSCs were intravenously administered with a low (1 3 10 5 cells/mouse) or high (2.5 3 10 5 cells/mouse) cell count ( Fig. 1D ). We then examined the mouse survival rates and bacterial CFUs in the lungs. MSC-injected mice had a significantly higher rate of survival over 15 days in a dose-dependent manner compared with the PBS-injected group (Fig. 1E ). The bacterial CFUs in the lungs were decreased by more than two log scales when the mice were injected with a high dose of MSCs (Fig. 1F ).
To investigate whether MSCs could affect the production of inflammatory cytokines and the recruitment of immune cells into the bronchoalveolar space following aerogenic M. abs-R infection, BALF was obtained from mice at day 5 postinfection. The cells within the BALF were stained and counted to determine the type of cells recruited into the bronchoalveolar space. As shown in Fig. 2A -2D, the recruitment of F4/ 80 -CD11b mid CD11c mid monocytes, F4/80 1 CD11b high CD11c low macrophages, CD4 1 and CD8 1 T cells into the bronchoalveolar space was significantly elevated by MSC administration. In addition, IFN-c, TNF-a, IL-6, MCP-1, NO, and PGE 2 levels in the BALF were also significantly increased by MSCs ( Fig. 2E ). However, IL-12p70, IL-4, IL-10, and IL-17 levels were not changed following MSC administration.
We next examined immune responses and the recruitment of immune cells into the bronchoalveolar space at 10 days post-infection. Overall, the characteristics of the cytokine profiles and the recruitment of immune cells were similar at 5 and 10 days post-infection, but the numbers of each type of cytokine and infiltrated immune cell were lower than 5 days post-infection (Supporting Information Fig. S2A, S2B ). In contrast, IL-10 levels were higher in the BALF at day 10 than at day 5 post-infection (Supporting Information Fig. S2A ).
MSCs Inhibit M. abs-R Growth in BMDMs
Although the above results indicated that MSCs could suppress M. abs-R growth in mice, we could not exclude the possibility that MSCs have a direct killing effect on bacteria that enhances their ability to control bacterial growth in macrophages. To confirm this possibility, we infected BMDMs with M. abs-R (multiplicity of infection, MOI 5 1) and measured intracellular growth for 72 hours. We tested the effect of MSCs on M. abs-R growth in BMDMs under three different conditions, as follows: a direct contact coculture condition to assess the influence of cell-cell interactions, an indirect coculture condition using transwell plates to identify soluble factor crosstalk, and a culture condition with MSC CM to identify soluble factor crosstalk. Unexpectedly, MSCs did not inhibit the growth of M. abs-R in BMDMs in any of the three conditions ( Fig. 3A ), suggesting that additional factors were required to inhibit bacterial growth in these conditions. IFN-c, an important activator of macrophages, is a cytokine that is critical for innate and adaptive immunity against bacterial infection, including M. abscessus [21] . Thus, we examined whether IFN-c treatment could alter the unexpected results in the three conditions described above. Interestingly, IFN-c treatment resulted in suppressed M. abs-R growth in all three conditions. The strongest antibacterial effect was found when the MSCs were directly cultured with the M. abs-R-infected BMDMs. Moreover, bacterial growth was also significantly inhibited when MSC CM was added to the M. abs-R-infected BMDMs (Fig. 3B ).
Because the strongest antibacterial effect was observed when the MSCs were directly cultured with the infected BMDMs, we sought to determine whether MSCs directly attach to macrophages. As shown in Supporting Information Fig. S3B , we found that F4/80-negative MSCs were directly attached to F4/80-positive BMDMs. In addition, MSCs strongly inhibited M. abs-R-RFP growth in BMDMs (Supporting Information Fig. S3 ). However, we did not identify any specific cell-cell chemotactic interaction between MSCs and M. abs-R infected BMDMs.
It has been shown that murine and hMSCs are largely different in terms of immunomodulatory processes [1] . We therefore examined whether hMSCs could also inhibit bacterial growth in the THP-1 human macrophage cell line. As shown in Supporting Information Fig. S4A , when grown in the presence of IFN-c, hMSCs inhibited M. abs-R growth.
Therefore, MSCs inhibit M. abs-R growth in macrophages in the presence of IFN-c. In addition, the MSCs secrete specific soluble factors that are involved in regulating the intracellular pathogens, which are controlled by cellular crosstalk between soluble factors and cell-cell interactions.
MSCs Increase NO Production in M. abs-R-Infected BMDMs Through Upregulating NF-jB Signaling
To investigate the macrophage-killing mechanisms that are potentially responsible for the effects of treatment with MSCs, we analyzed nitric oxide (NO) production using a transwell system. As shown in Fig. 4A , NO production was significantly increased when MSCs were cocultured in the presence of IFN-c. Because MSCs also produce NO, we measured NO levels in MSCs cultured without macrophages. However, low levels of NO were detected in the media of the MSCs that were cultured alone, and NO levels were slightly increased when cells were grown in the presence of IFN-c ( Fig. 4A ). Next, we examined inducible NO synthase (iNOS) expression in BMDMs and MSCs. After BMDMs and MSCs were cocultured, we divided the cells and subsequently measured iNOS expression. As shown in Fig.  4B , the iNOS mRNA and protein levels in the BMDMs were significantly higher when the cells were cocultured with MSCs in the presence of IFN-c. However, iNOS mRNA and protein levels were undetectable in MSCs when we loaded the same amounts of protein and mRNA that we used to detect their expression in macrophages. We further confirmed these results using immunocytochemistry ( Fig. 4C) .
We further investigated NO production under the three different culture conditions described above. As expected, the highest levels of NO production were observed in MSCs directly cocultured with M. abs-R-infected BMDMs. No increases in production occurred in the conditions in which MSCs were cocultured with M. abs-R-infected BMDMs using transwell plates and in which MSCs were cultured with CM. Interestingly, higher NO levels were detected in MSC transwell coculture compared with CM treatment (Supporting Information Fig. S5A ). These results suggested potential soluble factor crosstalk. To confirm this possibility, we first collected CM from BMDMs with or without M. abs-R infection in the presence of IFN-c and then cultured MSCs with the CM for 24
Kim, Cha, Kim et al. 5 www.StemCells.com V C AlphaMed Press 2016 hours. After incubation, we collected the MSC CM and used it to treat M. abs-R-infected-BMDMs in the presence of IFN-c before measuring NO production. As shown in Supporting Information Fig. S5B , the CM from MSCs stimulated with M. abs-R-infected BMDM CM produced a higher amount of NO than MSC CM from incubation with uninfected BMDM CM. However, a small amount of NO was detected in all of the CM samples (Supporting Information Fig. S5C ).
Next, we investigated whether hMSCs could also induce NO production in M. abs-R-infected THP-1 cells. Although a relatively smaller amount (less than 5 mM) was observed in these cultures than was observed in the mouse systems, the results showed a trend similar to that described above (Supporting Information Fig. S4B ).
To investigate whether the upregulation of iNOS improved the ability of macrophages to kill M. abs-R, we used the NO Figure 2 . Effects of MSCs on cytokine production and cellular influx into the bronchoalveolar space. C57BL/6J mice were aerogenically infected with 5 3 10 4 M. abs-R cells, and MSCs (2.5 3 10 5 ) were then injected via the tail vein 1 day after infection. (A): Immune cells in the lungs were harvested at day 5 post-infection, and the cells were assayed by flow cytometry. The representative dot-blot was primarily gated on FSC mid/high /SSC mid/high and secondarily gated on F4/80 high or F4/80 low . F4/80 high /CD11b high /CD11c low/mid cells were classified as CD11b high macrophages, and F4/80 low /CD11b low /CD11c high cells were classified as alveolar macrophages. F4/80 low /CD11b mid / CD11c mid cells were classified as monocytes, and F4/80 low /CD11b high /CD11c high cells were classified as CD11b high dendritic cells. F4/ 80 low /CD11b low /CD11c high cells were classified as CD11b low dendritic cells. MSCs Enhance the Antimycobacterial Activity V C AlphaMed Press 2016 synthase inhibitor L-NMMA. The addition of L-NMMA to the infected BMDMs cocultured with MSCs caused almost complete inhibition of NO production and intracellular killing activity against M. abs-R (Fig. 4A, 4D) .
Interestingly, we found that adding L-NMMA to M. abs-Rinfected THP-1 cells that were cocultured with hMSCs also completely inhibited NO production but only partially inhibited intracellular killing activity against M. abs-R (Supporting Information Fig. S4C ).
Previous studies have shown that iNOS expression of macrophage is regulated by signal integration between IFN-c and TLR, which are involved in the interactions among STAT-1, interferonregulated factor 1 (IRF-1), p38 and NF-jB [33, 34] . Because the data showed that MSCs induced iNOS expression in BMDMs, we examined the associated signal transduction pathway. As shown in Fig. 4E , MSCs induced IjBa degradation and p65 translocation from the cytosol to the nucleus but did not alter p38 phosphorylation, STAT-1 phosphorylation or IRF-1 expression. Furthermore, MSC-induced NO production was attenuated by the NF-jB inhibitor Bay-11-7082 but not by the p38 inhibitor SB203580 (Supporting Information Fig. S6A, S6B) . Consistent with the above results, NF-jB inhibitor treatment resulted in a marked inhibition of the MSC-induced enhancement of BMDM killing activity against M. abs-R (Fig. 4F ). Taken together, these results indicate that MSC-induced NO production in infected BMDMs is mediated by NF-jB but not by p38 or STAT1-IRF1.
Effect of MSCs on Cytokine Production of M. abs-R-Infected BMDMs
We hypothesized that MSCs might alter the cytokine production of M. abs-R-infected BMDMs. Therefore, we assessed the levels of TNF-a, IL-6, IL-12p70, IL-10, and PGE 2 produced by BMDMs cocultured with MSCs in transwell plates. When the BMDMs were infected with M. abs-R at an MOI of 1 in the absence of IFN-c, low levels of TNF-a, IL-6, IL-12p70, and PGE 2 were detected in the culture medium. However, high levels of TNF-a, IL-6, and IL-12p70 were produced from M. abs-Rinfected BMDMs in the presence of IFN-c. IL-10 was also detected in the culture medium of infected BMDMs but was not affected by IFN-c. Interestingly, the coculture of infected BMDMs with MSCs strongly increased the production levels of IL-6 and PGE 2 , but the levels of TNF-a and IL-12p70 in the presence of IFN-c and IL-10 remained unchanged in this condition (Supporting Information Fig. S7A-S7E ). As previous studies have shown that MSCs produce several types of cytokines [35] , we measured the production of the above-mentioned cytokines from MSCs. As shown in Supporting Information Fig. S7A-S7E , MSCs secreted high levels of IL-6, IL-10 and PGE 2 and low levels of TNF-a and IL-12p70. Because IL-6, IL-10, and PGE 2 are produced by both cell types, we examined IL-6 and Cox-2 mRNA levels in BMDMs and MSCs, respectively, in our coculture system. As shown in Supporting Information Fig. S7F , IL-6 expression levels were increased in both cell types and were higher in cells grown with IFN-c. IL-10 was expressed mainly in BMDMs, whereas Cox-2 was detected mainly in MSCs that were cocultured with M. abs-R-infected BMDMs in the presence of IFN-c.
MSC-Derived PGE 2 is a Key Regulator of NO Production by BMDMs
Because IL-6 levels were synergistically increased in our coculture system, we tested whether IL-6 was important for the action of MSCs by treating M. abs-R-infected BMDMs with recombinant IL-6 protein or a monoclonal antibody against the a-chain of the IL-6 receptor to block IL-6 signal transduction. Unexpectedly, neither recombinant IL-6 nor the monoclonal antibody against the IL-6 receptor affected the production of NO in infected BMDMs (Supporting Information Fig. S8A, S8B) . These results suggested that IL-6 is not a major mediator of NO production in this system. Thus, we focused on PGE 2 , which was also synergistically increased in our coculture system. We examined the effect of celecoxib, a specific PGE 2 inhibitor, on NO production. As expected, PGE 2 inhibition resulted in a significant reduction of NO production in our coculture system. In addition, this decrease was recovered by adding exogenous PGE 2 (Fig. 5A) . The anti-bacterial effects of MSCs were completely attenuated by treatment with celecoxib, and this attenuation recovered when exogenous PGE 2 was added (Fig. 5B) . To further examine the effect of PGE 2 on the production of NO and on the bacterial CFUs in the presence of IFN-c, we infected BMDMs with M. abs-R and added exogenous PGE 2 without MSCs. With the addition of PGE 2 in the presence of IFN-c, NO production significantly increased, and bacterial CFUs gradually decreased, as shown in Fig. 5C, 5D . Therefore, these results suggested that PGE 2 is a major mediator of NO production in this system.
The Cellular Basis for BMDM-MSC Interactions
To understand the molecular mechanism of the increase in NO production caused by MSCs through PGE 2 in M. abs-Rinfected BMDMs, we focused on TNF-a because it was greatly changed by IFN-c (Supporting Information Fig. S7A ). To investigate whether TNF-a plays a key role in BMDM-MSC crosstalk, we measured the level of NO production in the coculture medium from cells treated with or without a TNF-a neutralizing antibody. The amount of NO was significantly decreased in the TNF-a-neutralized group, and this effect was recovered with the addition of exogenous PGE 2 (Fig. 6A) . Similarly, when M. abs-R-infected BMDMs were cocultured with MSCs in the presence of the TNF-a neutralizing antibody, the CFUs were not reduced. Moreover, the CFUs were reduced in this condi-tion when exogenous PGE 2 was added (Fig. 6B) . These results suggest that the IFN-c-stimulated upregulation of TNF-a in the cocultures plays a key role in BMDM-MSC crosstalk.
Therefore, to investigate whether PGE 2 secretion from MSCs is regulated by TNF-a levels, we prepared CM from BMDMs with or without M. abs-R infection and cultured in the presence of IFN-c. After 24 hours, we collected the CM from the BMDMs and used it to treat MSCs with or without TNF-a neutralizing antibody. After 24 hours, we measured PGE 2 levels in the MSC culture medium. As shown in Fig. 6C , MSCs treated with CM from M. abs-R-infected BMDMs produced higher levels of PGE 2 than those treated with CM from uninfected BMDMs. Surprisingly, these effects were completely blocked by incubation with the TNF-a neutralizing antibody. We also found significantly increased Cox-2 expression in MSCs at 6 hours after stimulation with CM, which was collected from BMDMs with or without M. abs-R infection in the presence of IFN-c. However, when the MSCs were treated with a TNF-a neutralizing antibody, Cox-2 expression did not change (Fig. 6D) .
To further confirm the presence of cellular cross-talk, we used Cox-2 2/2 and iNOS 2/2 MSCs. As shown in Fig. 6E , NO production was observed when wild-type MSCs and iNOS 2/2 MSCs, but not Cox-2 2/2 MSCs, were cocultured with M. abs-R-infected BMDMs. Likewise, Cox-2 2/2 MSCs did not inhibit the growth of M. abs-R in BMDMs (Fig. 6F) . Taken together, these results suggested that the secretion of high levels of TNF-a from M. abs-R-infected BMDMs induced by IFN-c led to PGE 2 secretion by MSCs.
Effects of NO Inhibition on MSC-Induced M. abscessus Clearance in Mice
Although our in vitro data strongly suggest that NO is the main effector of MSC-induced M. abs-R clearance, whether NO is also an effecter of MSCs in mice is unknown. To extend our in vitro studies, we used aminoguanidine, a selective iNOS inhibitor, in the M. abs-R mouse infection model. C57BL/6J mice were infected with an aerosolized strain of M. abs-R and were then intravenously injected with MSCs at one day post-infection with or without aminoguanidine (Fig. 7A) . The iNOS inhibition resulted in a significant reduction of MSCinduced M. abs-R clearance (Fig. 7B ). Furthermore, iNOS expression in the lungs of MSC-injected mice was markedly increased compared with control mice (Fig. 7C) .
We next examined iNOS expression in F4/80 1 macrophages using immunohistochemical staining of lung tissue sections. When we merged the captured images, the majority of the iNOS expression was observed to colocalize with F4/80 1 cells when treated with wild type and iNOS 2/2 MSCs (Fig. 7D) .
Finally, to further confirm the results of our in vitro studies, we used Cox-2 2/2 and iNOS 2/2 MSCs in the abs-R mouse infection model. When mice were injected with wild type and iNOS 2/2 MSCs, we observed M. abs-R clearance in lung and spleens, but we did not observe clearance when mice were similarly treated with Cox-2 2/2 MSCs (Fig. 7E) . These data suggest that the NO that is produced by macrophages is a major effector molecule that is used by MSCs to control M. abs-R in mice.
DISCUSSION
Although NO has been described as an essential effector molecule for microbial killing within macrophages, the role of NO in mycobacteria remains controversial. NO has been shown to be essential for host defense against Mtb in murine models, but the role of NO has not been fully established in humans [36] . For example, failure to express iNOS resulted in the rapid proliferation of Mtb and early death in murine models [37] . However, NO was not found to be involved in the bacteria-killing mechanisms of M. avium-infected macrophages [38] . Regardless of this, NO still has an important role in defense against nontuberculous mycobacterial (NTM) diseases [39] .
In this study, our data clearly demonstrate that NO is specifically associated with host defenses that are aimed at controlling M. abscessus. Previous studies have shown that MSCs can generate NO, which exerts highly immunosuppressive effects at high concentrations via undefined mechanisms in murine models [40] . Although IFN-c can stimulate MSCs to release high levels of immunosuppressive factors [41, 42] , we detected less than 2 mM NO in the culture medium of MSCs that were treated with or without IFN-c. Therefore, in this study, the main source of NO in the coculture medium was macrophages, and IFN-c did not have any effect on the production of NO by MSCs. In addition, iNOS mRNA expression increased in macrophages but not in MSCs. In this study, our data in hMSCs and THP-1 cells demonstrated that NO levels are associated in part with host defenses against M. abscessus in humans because adding NMMA only partially abrogated the anti-bacterial abilities of hMSCs. This may be because hMSCs use indoleamine 2,3-dioxygenase instead of NO to exert their immunomodulatory functions [1, 4] . Therefore, hMSCs might employ another antibacterial mechanism to combat M. abscessus, and further studies are required to better define these molecular mechanisms in humans. According to a previous study, the systemic transplantation of autologous MSCs into multidrug-resistant pulmonary tuberculosis patients induced positive clinical effects, such as stopping bacterial discharge [43] . A clinical trial of an autologous MSC therapy for multidrug-resistant pulmonary tuberculosis patients has been ongoing since 2014 [44] . In contrast, recent studies have clearly shown that CD271 1 MSCs provide a long-term protective intracellular niche in the host in which dormant Mtb can reside, and this provides an antibioticprotective niche for Mtb [13, 14] . Therefore, endogenously administered MSCs and exogenously administered MSCs may behave differently in response to Mycobacterium spp. depending on individual immune conditions. According to recent studies, a strong inflammatory response is important for prompting the immunosuppressive functions of MSCs [1, 4] . However, insufficient inflammatory cytokines can stimulate MSCs to produce chemokines and trophic factors, which enhance immune responses [1] . In addition, IL-10 has been shown to suppress the effects of MSC activities [1] . It is noteworthy that the secretion of high amounts of IL-10 was detected in M. abscessus-infected macrophages that were cultured with or without IFN-c. Thus, the inflammatory status of the host may determine the immunomodulatory properties of MSCs. In this study, M. abs-Rinfected (MOI 5 1) macrophages induced low levels of proinflammatory cytokines. When M. abs-R-infected macrophages were treated with IFN-c, the production of proinflammatory cytokines was slightly increased. Accumulating evidence has suggested that a low Th1 cell response, low levels of Th1associated cytokines such as TNF-a and IFN-c, and a delayed infiltration of innate immune cells such as monocytes and macrophages into the lungs could be associated with host susceptibility to the development of NTM disease [22, 45] . In this study, we found that MSCs lead to the increased recruitment of inflammatory cells such as monocytes, CD11b high macrophages, and CD4 1 and CD8 1 T cells to the lungs in mice infected with M. abs-R compared with M. abs-R-infected mice not injected with MSCs. The production of proinflammatory cytokines, including IFN-c, IL-6, TNF-a and MCP-1, in the lungs of M. abs-R-infected mice was also increased by MSC injection. Consequently, our data show that MSCs may perform opposite functions depending on the inflammatory condition, which is in agreement with previous reports [1, 5, 7] .
MSCs constitutively produce detectable levels of PGE 2 . Under inflammatory conditions, PGE 2 production is induced, causing a marked increase in the amount of PGE 2 secreted by MSCs [40] . Proinflammatory cytokines such as TNF-a, IL-1b, and IFN-c as well as LPS are direct regulators of PGE 2 production by MSCs [46] . PGE 2 released by MSCs can reprogram macrophages to produce additional IL-10, thus shifting the balance between Th1 and Th2 cells [8, 46] . In this study, we also showed that MSCs produced higher levels of PGE 2 in the presence of TNF-a, which is upregulated by IFN-c. However, we did not observe an effect on IL-10 secretion in M. abs-Rinfected macrophages in the presence or absence of IFN-c by MSCs. These results were partially in agreement with a previous report [8] . Although many studies have reported enhanced IL-10 production by PGE 2 , our study suggests that an inflammatory condition such as infection affects the regulation of IL-10 expression by PGE 2 . However, further studies are required to better understand the specific nature of the relationship between PGE 2 and IL-10 secretion in M. abscessus-infected macrophages.
Soluble factors produced by MSCs have been suggested to possess immune-regulatory properties [8] . In this study, we compared the NO production levels of macrophages in three conditions (cell-to-cell contact, transwell plates, and CM) to test whether soluble factors produced by MSCs are critical for NO production in macrophages. According to our data, the highest NO production was found when there was direct contact between MSCs and macrophages, indicating that cell-tocell contact is necessary for the production of NO in macrophages in this context. The molecules produced by MSCs that are involved in the direct interaction with macrophages have not been reported, and the mechanisms that significantly amplify NO production when macrophages are in direct contact with MSCs are also unknown. Thus, the identification of molecules involved in the direct interaction between MSCs and macrophages will help to verify the mechanism of increased NO production in macrophages and will determine the applicability of MSCs for therapeutic use in infectious diseases.
Recent studies have begun to shed light on the roles of eicosanoids in mycobacterial infection [47] [48] [49] . PGE 2 , an essential factor in cell membrane protection, is a lipid mediator derived from arachidonic acid. The infection of macrophages with virulent H37Rv Mtb induces lipoxin A4 production and blocks Cox-2 and PGE 2 production, leading to the necrotic death of Mtb-infected macrophages [47] [48] [49] . Because these previous studies have focused on the role of PGE 2 in determining the type of cell death that occurs in infected macrophages, the effector role of PGE 2 and the killing mechanisms against mycobacterial spp. remain poorly understood. Therefore, our results provide important evidence that PGE 2 elevates IFN-c-induced NO production, resulting in increased intracellular pathogen clearance. Further studies are needed to explore the molecular mechanisms of PGE 2 -induced NO production in macrophages.
SUMMARY
In summary, MSCs enhance NO production in M. abs-Rinfected macrophages by inducing the secretion of PGE 2 , which results in the inhibition of M. abs-R growth. TNF-a, which is upregulated by IFN-c in macrophages, may play an important role the production of PGE 2 in MSCs. Therefore, MSCs may facilitate IFN-c-mediated immunity by increasing IFN-c signaling in macrophages. MSCs contribute to the ability of macrophages to protect against mycobacteria, and they may therefore represent a novel therapeutic alternative to antibiotics. Because MSCs can be successfully used in human 12 MSCs Enhance the Antimycobacterial Activity V C AlphaMed Press 2016 applications, further studies may lead to the development of new approaches or interventions that use MSCs to treat previously untreatable mycobacterial infections.
